CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.04 ($120,269)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $21.33 ($69,321)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.50 ($22,505)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 12,500 shares at $20.61 ($257,575)
- 4 Planned sale PRESIDENT AND CEO sold 12,500 shares at $20.83 ($260,320)
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 12 of 40 · 798 filings